A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence

Single-Dose Interaction Study of the Arginine Vasopressin Type 1B Receptor Antagonist ABT-436 and Alcohol in Moderate Alcohol Drinkers

(2016) David A. Katz et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Existing and Future Drugs for the Treatment of the Dark Side of Addiction

(2016) George F. Koob et al.   Annual Review of Pharmacology and Toxicology

Heterogeneity of Alcohol Use Disorder: Understanding Mechanisms to Advance Personalized Treatment

(2015) Raye Z. Litten et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

2010 National and State Costs of Excessive Alcohol Consumption

(2015) Jeffrey J. Sacks et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals

(2015) Leandro F. Vendruscolo et al.   JOURNAL OF CLINICAL INVESTIGATION

Chronic Nicotine Activates Stress/Reward-Related Brain Regions and Facilitates the Transition to Compulsive Alcohol Drinking

(2015) Rodrigo M. Leão et al.   JOURNAL OF NEUROSCIENCE

Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436

(2015) David A. Katz et al.   PSYCHOPHARMACOLOGY

Epidemiology ofDSM-5Alcohol Use Disorder

(2015) Bridget F. Grant et al.   JAMA Psychiatry

Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence

(2014) Jie Wu et al.   ACTA PHARMACOLOGICA SINICA

Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis

(2014) M. Roerecke et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

(2013) Raye Z. Litten et al.   Journal of Addiction Medicine

Alcohol and Tobacco: How Smoking May Promote Excessive Drinking

(2013) Jonathan P. Britt et al.   NEURON

Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

(2012) Natalya C. Maisel et al.   ADDICTION

Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats

(2011) Scott Edwards et al.   ADDICTION BIOLOGY

Involvement of Arginine Vasopressin and V1b Receptor in Alcohol Drinking in Sardinian Alcohol-Preferring Rats

(2011) Yan Zhou et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Biological mechanisms underlying the relationship between stress and smoking: State of the science and directions for future work

(2011) Jessica M. Richards et al.   BIOLOGICAL PSYCHOLOGY

Corticotropin Releasing Factor–Induced Amygdala Gamma-Aminobutyric Acid Release Plays a Key Role in Alcohol Dependence

(2010) Marisa Roberto et al.   BIOLOGICAL PSYCHIATRY

A Double-Blind Trial of Gabapentin Versus Lorazepam in the Treatment of Alcohol Withdrawal

(2009) Hugh Myrick et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Salting-out assisted liquid/liquid extraction with acetonitrile: a new high throughput sample preparation technique for good laboratory practice bioanalysis using liquid chromatography-mass spectrometry

(2008) Jun Zhang et al.   BIOMEDICAL CHROMATOGRAPHY

A prospective study of risk drinking: At risk for what?

(2008) Deborah A. Dawson et al.   DRUG AND ALCOHOL DEPENDENCE

A Role for Brain Stress Systems in Addiction

(2008) George F. Koob   NEURON

Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism

(2008) D. T. George et al.   SCIENCE